Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Learn why index funds are a popular choice for retirement, offering broad market exposure, low fees, and straightforward, scalable strategy.
24,587 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
The Netherlands now boasts a 32-hour average workweek, led by women in the workforce. The trend reshapes productivity...
Nike is back in focus as consumer demand shows resilience and the market digests the athletic giant's performance. Th...
Salesforce plans up to $25 billion in debt to fund an accelerated share repurchase that would buy back roughly 14% of...
A sharp look at how perfectly rational branding decisions can erode meaning. Intel and Toyota illustrate why investor...
Lucid Diagnostics (LUCD) is navigating reimbursement and adoption as it scales its non-invasive tests. This analysis ...
This comprehensive guide breaks down Exzeo’s Q1 2026 results, reveals the drivers behind exzeo (xzo) 2026 earnings, a...
AI-driven prompts are accelerating impulsive trades in a choppy market. This report examines how human oversight can ...
Pershing Square signals a bold bet by leaning into Microsoft as the AI and cloud wave reshapes enterprise tech. The m...
A practical guide to understanding finvolution (finv) 2026 earnings, what to watch in the Q1 transcript, and how to p...
A software stock that doubled since April caught my eye for reasons beyond hype. In this guide, I explain the growth ...
In 2026, a rising rate environment and tighter underwriting are driving HELOC denials. This report explains how to re...